Global 3D Printed Drugs Market Insight Report Offers Growth Opportunities 2020 to 2026
The global 3D printed drugs market was valued at USD 214.3 million in 2017, and is projected to reach USD 295.5 million by 2025, growing at a CAGR of 4.2% during 2018–2025.
Major factors propelling the market growth for 3D printed drugs include technological innovations in 3D printing procedures, user-friendly and easy availability. Moreover, the ability to print drugs on-demand could reduce cost, increase the choice available to clinicians, reduce the risk of counterfeiting, and help personalize drug delivery to the needs of individual patients.
Request Sample Report Now at – https://www.gmiresearch.com/report/global-3d-printed-drugs-market-by-technique-type/sample-request
Based on technology type, Fused Deposition Modelling technology is anticipated to lead the market during 2018-2025
Fused Deposition Modelling is expected to hold the largest share in the market during the forecast period due to innovations and technological advancement in the field of pharmaceutical drugs. Inkjet Printer technology type is predicted to exhibit a high growth rate during the forecast period owing to surging adoption among patients due to its characteristics, such as producing 3D Drugs tablets at a constant rate and technologically advanced properties.
Fused Deposition Modelling is expected to hold the largest share in the market during the forecast period due to innovations and technological advancement in the field of pharmaceutical drugs. Inkjet Printer technology type is predicted to exhibit a high growth rate during the forecast period owing to surging adoption among patients due to its characteristics, such as producing 3D Drugs tablets at a constant rate and technologically advanced properties.
Key market players are investing a lot in the research & development activities. The companies are focusing on partnerships for developing 3D printed drugs.
North America held the largest share in global 3D printed drugs market in 2017, owing to growth in government and private funding on healthcare infrastructure, growing awareness about the drugs and increased technological awareness in the pharmaceutical industry. Asia-Pacific is predicted to be the second most attractive regional market in the 3D printed drugs market, globally, and is likely to show the maximum growth in the next few years.
Speak to Research Analyst to Understand more About Research at : https://www.gmiresearch.com/report/global-3d-printed-drugs-market-by-technique-type/
Various notable players operating in the global 3D printed drugs market include 3D Printer Drug Machine, Aprecia Pharmaceuticals, FabRx Ltd, GlaxoSmithKline Plc., Hewlett Packard Caribe, BV, National University of Singapore, The University of Nottingham, UCL School of Pharmacy, University College of London, University of Glasgow and others.
The global 3D printed drugs market has been segmented on the basis of technique type and key geographies. Based on technique type, the market comprises of fused deposition modeling, inkjet printer, and others and key geographical areas.
The research report global 3D Printed Drugs market provides an in-depth analysis of the 3D printed drugs market, globally, based on technology type and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by the market participants. The research report provides market size and forecast for 3D drugs market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.
Request for Customization at – https://www.gmiresearch.com/report/global-3d-printed-drugs-market-by-technique-type/request-for-customization
Key questions answered in this research report:
- At what pace is the 3D printed drugs market growing worldwide? What will be the growth trend in the future?
- What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the coming years?
- What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the global 3D printed drugs market?
- What are the various application areas and how they are poised to grow?
About GMI Research
GMI Research provides research and consulting solutions to our clients. We help our global clients through independent fact-based insights, ensuring their business achieve success by beating the competition. We provide syndicated research, customized market and competitive intelligence research, sales enablement support and data analytics services.
Contact Us
GMI Research
Level 1, The Chase Carmanhall Road, Sandyford Industrial Estate,
Dublin D18 Y3X2, Ireland
Ph. No: +353 1 442 8820
Email: enquiry@gmiresearch.com
Web: https://www.gmiresearch.com
Level 1, The Chase Carmanhall Road, Sandyford Industrial Estate,
Dublin D18 Y3X2, Ireland
Ph. No: +353 1 442 8820
Email: enquiry@gmiresearch.com
Web: https://www.gmiresearch.com
Comments
Post a Comment